These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16314822)

  • 1. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.
    Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TGF-beta signaling pathway in pancreatic cancer cells].
    Ijichi H
    Nihon Rinsho; 2004 Jul; 62(7):1241-8. PubMed ID: 15283139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant gata-3 expression in human pancreatic cancer.
    Gulbinas A; Berberat PO; Dambrauskas Z; Giese T; Giese N; Autschbach F; Kleeff J; Meuer S; Büchler MW; Friess H
    J Histochem Cytochem; 2006 Feb; 54(2):161-9. PubMed ID: 16087702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and signaling pathways.
    Kelly DL; Rizzino A
    Anticancer Res; 1999; 19(6A):4791-807. PubMed ID: 10697593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New regulatory mechanisms of TGF-beta receptor function.
    Kang JS; Liu C; Derynck R
    Trends Cell Biol; 2009 Aug; 19(8):385-94. PubMed ID: 19648010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease.
    Rane SG; Lee JH; Lin HM
    Cytokine Growth Factor Rev; 2006; 17(1-2):107-19. PubMed ID: 16257256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release.
    Ikeda O; Egami H; Ishiko T; Ishikawa S; Kamohara H; Hidaka H; Takahashi M; Ogawa M
    Int J Oncol; 2006 Apr; 28(4):939-46. PubMed ID: 16525644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
    Pen A; Moreno MJ; Durocher Y; Deb-Rinker P; Stanimirovic DB
    Oncogene; 2008 Nov; 27(54):6834-44. PubMed ID: 18711401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
    Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Smad TGF-beta signals.
    Moustakas A; Heldin CH
    J Cell Sci; 2005 Aug; 118(Pt 16):3573-84. PubMed ID: 16105881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
    Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
    Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and cancer: a love-hate relationship?
    Reiss M
    Oncol Res; 1997; 9(9):447-57. PubMed ID: 9495450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta signalling in colon carcinogenesis.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Cancer Lett; 2012 Jan; 314(1):1-7. PubMed ID: 22018778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of the stoichiometric control of Smad complex formation in TGF-beta signal transduction pathway.
    Nakabayashi J; Sasaki A
    J Theor Biol; 2009 Jul; 259(2):389-403. PubMed ID: 19358856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.